Atorvastatin Calcium

Product NDC: 50090-5208
11-digit product format: 500905208
Labeler code: 50090
Product ID: 50090-5208_30197096-f692-4854-8f37-e4eb1e10944b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atorvastatin Calcium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA209288
Marketing category: ANDA
Marketing start: 2018-12-23
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 40 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A209288-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A209288-001	AB
A209288-002	AB
A209288-003	AB
A209288-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209288-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209288-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209288-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209288-004	AB	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: Atorvastatin Calcium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATORVASTATIN CALCIUM TRIHYDRATE	40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
48A5M73Z4Q	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
617311	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1cc2dd41-a465-45b6-a80a-67c41af29cf8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-5208-0	Atorvastatin Calcium	90 in 1 BOTTLE	TABLET, FILM COATED	90		7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-5208-0	EA - Each	50090-5208	0c027ffa-892b-41d1-ae15-b4f2646c6abe	1	2024-05-16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-5208	ATORVASTATIN CALCIUM TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]	7	Current NDC, Legacy NDC, 1 package rows	20240417_1cc2dd41-a465-45b6-a80a-67c41af29cf8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atorvastatin Calcium	ATORVASTATIN CALCIUM	REMEDYREPACK INC.	09cb8375-075c-47e8-a4eb-8ac667ed849e	2026-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	c9f55cb6-a41b-dd27-e053-2a95a90aaeb7	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	f3084cae-db82-4e6f-e053-2995a90aa36a	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	da6b77a5-2093-b7f7-e053-2995a90ab10d	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	QPharma, Inc.	bd216f5d-f319-7d8d-e053-2a95a90aa9ce	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	QPharma, Inc.	c0e2a5d0-1aa3-e131-e053-2a95a90a9870	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	REMEDYREPACK INC.	57f9b462-f08e-483c-9b64-b7e4c8d46927	2025-09-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Asclemed USA, Inc.	60d51f39-8086-4434-affe-88ab8ca0c7e5	2025-05-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Ascend Laboratories, LLC	67e60880-091a-4df7-8696-6e6c42a490e2	2025-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Bryant Ranch Prepack	2035c49b-f319-4dce-bf1c-c2f64e786fb7	2025-01-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	95729689-8055-45ae-e053-2995a90a919f	2024-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	8ee8b455-625c-ead6-e053-2a95a90aed29	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	862f9f27-c645-2d2e-e053-2991aa0a96b9	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	862f58d1-476c-2c90-e053-2991aa0ab821	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	1cc2dd41-a465-45b6-a80a-67c41af29cf8	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288 ndc (product): 50090-5208
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	2ad89657-cc95-44a0-af6a-ee756526aa10	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	103cc381-3266-409d-bdc2-1de620bae355	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	e52b4b11-9618-4787-ae67-44e4a3166dfb	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	0ec97c59-9d17-45f8-93f9-2c1f0361cb75	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	e6d068ed-f9d2-4fd1-9755-b76bea89725e	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	1cc2dd41-a465-45b6-a80a-67c41af29cf8	7
617311	atorvastatin 40 MG Oral Tablet	SCD	1cc2dd41-a465-45b6-a80a-67c41af29cf8	7
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	1cc2dd41-a465-45b6-a80a-67c41af29cf8	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-5208-0	50090520800	90 TABLET, FILM COATED in 1 BOTTLE (50090-5208-0)	2020-10-05	0000-00-00	No	No	Current